EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis

Per-Jostein Samuelsen iD, Björn Wettermark iD, Fredrik Nyberg iD, Mohammadhossein Hajiebrahimi iD

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.14119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Per-Jostein Samuelsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Regional Medicines Information and Pharmacovigilance Centre (RELIS), University Hospital of North Norway, Tromso, Norway. Hauptthemen laut MEDLINE: Anticoagulants, COVID-19, Interrupted Time Series Analysis, Warfarin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID‐19 pandemic may have increased anticoagulant initiation due to the thrombogenic nature of the disease or decreased due to the societal impact of the pandemic. We aimed to study the effect of the COVID‐19 pandemic on initiation of anticoagulants in Sweden. We conducted a single interrupted time series analysis on the monthly cumulative incidence of nonvitamin K antagonist oral anticoagulants (NOAC), warfarin, or heparins, before and after March 2020, using SCIFI‐PEARL dataset. For anticoagulants in total, there were no statistically significant changes or differences in the trends of initiation after the start of the pandemic. There was a slight numerical decrease in initiation after the onset of the pandemic, particularly for NOACs. For individuals aged ≥ 65 years, however, the immediate decrease in initiation was considerable for NOACs. The prepandemic declining trend of warfarin initiation seemed to attenuate, that is, became less negative, after March 2020. We did not find any profound effect of the COVID‐19 pandemic on the initiation of anticoagulants in total. However, among individuals aged ≥ 65 years, a notable immediate decrease in initiation of NOACs was observed. Furthermore, the onset of the pandemic may have attenuated the downward temporal trend in initiation of warfarin use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsCOVID-19Interrupted Time Series AnalysisWarfarinHumansSwedenAgedAdministration, OralMiddle AgedMaleAged, 80 and overFemaleSARS-CoV-2PandemicsHeparin

Stichwörter der Autor:innen

COVID‐19ITS studyNOACanticoagulantsheparin

Substanzen

AnticoagulantsWarfarinHeparin

Autor:innen und Institutionen

  • Regional Medicines Information and Pharmacovigilance Centre (RELIS), University Hospital of North Norway, Tromso, Norway.
  • Pharmacoepidemiology, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Per-Jostein Samuelsen, Björn Wettermark, Fredrik Nyberg, Mohammadhossein Hajiebrahimi

Zitieren

APA

Samuelsen, P. J., Wettermark, B., Nyberg, F., & Hajiebrahimi, M. (2025). Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14119

Vancouver

Samuelsen PJ, Wettermark B, Nyberg F, Hajiebrahimi M. Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.14119

BibTeX
@article{Samuelsen2025,
  author = {Samuelsen, Per-Jostein and Wettermark, Björn and Nyberg, Fredrik and Hajiebrahimi, Mohammadhossein},
  title = {Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.14119}
}
Kostenlos starten →